Drug-induced dementia: A case/non-case study in the French pharmacovigilance database;Démences médicamenteuses: Étude cas/non-cas dans la banque nationale de pharmacovigilance

Therapie

Volumn 62, Issue 6, 2007, Pages 507-511

  Favrelière, Sylvie ^a   Lafay Chebassier, Claire ^a   Alkhidir, Fuad ^a   Merlet, Isabelle ^a   Pochat, Marie Christine Pérault ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adverse effect; Case non case study; Dementia; Pharmacovigilance

Indexed keywords

ACEPROMETAZINE; ALLOPURINOL; ALPHA2B INTERFERON; AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUPRENORPHINE; CLORAZEPATE; DIGITOXIN; FLUNITRAZEPAM; FLUOXETINE; HYPNOTIC AGENT; LITHIUM CARBONATE; LORAZEPAM; MORPHINE; NEUROLEPTIC AGENT; PAROXETINE; TRIHEXYPHENIDYL; TRIMEBUTINE; VALPROIC ACID; VANCOMYCIN; ZOLPIDEM;

ADOLESCENT; ADULT; AGED; ANTEROGRADE AMNESIA; ARTICLE; CHILD; CONFUSION; CONTROLLED STUDY; DATA BASE; DELIRIUM; DEMENTIA; DEPERSONALIZATION; DISEASE ASSOCIATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT DURATION;

EID: 48749120276     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2007070     Document Type: Article

References (23)

1. Letenneur L, Dequae L, Jacqmin H, et al. Prévalence de la démence en Gironde. Rev Epidemiol Sante Publique 1993; 41: 139-45
2. Ramaroson H, Helmer C, Barbeger-Gateau P, et al. Prévalence des démences et de la maladie d'Alzheimer parmi les sujets de plus de 75 ans : résultats actualisés de la cohorte Paquid. Rev Neurol 2003; 159: 405-11
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed (DSM IV). Washington DC: APA; 1994
4. Minger SL, Esiri MM, Mc Donald B, et al. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology 2000; 55: 1460-7
5. Nazarali AJ, Reynolds GP. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a post-mortem study. Cell Mol Neurobiol 1992; 12: 581-7
6. Engelborghs S, De Deyn PP. The neurochemistry of Alzheimer's disease. Acta Neurol Belg 1997; 97: 67-84
7. Byerly MJ, Weber MT, Brooks DL, et al. Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs Aging 2001; 18: 45-61
8. Platt JE, Campbell M, Grenn WH, et al. Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Arch Gen Psychiatry 1984; 41: 657-62
9. Engelsmann F, Kaltz J, Ghadirian AM, Schachter D. Lithium and memory: a long term follow-up study. J. Clin Psychopharmacol 1988; 8: 207-12
10. Masmoudi K, Gras-Champel V, Bonnet I, et al. Démence et troubles extrapyramidaux sous acide valproïque au long cours. Thérapie 2000; 55: 629-34
11. Armon C, Shin C, Miller P, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996 ; 47: 626-35
12. Edwards RA, Medlicott RW. Advantages and disadvantages of benzodiazepine prescription. N Z Med J 1980; 92: 357-9
13. Hulse GK, Lauthenschlager NT, Tait RJ, Almeida OP. Dementia associated with alcohol and other drug use. Int Psychogeriatr 2005; 17: S109-27
14. Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35: 307-15
15. Mintzer MZ, Griffiths RR. Triazolam and zolpidem: effects on memory and attentional processes. Psychopharmacology 1999; 144: 8-19
16. Berlin I, Warot D, Hergueta T, et al. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 1993; 13: 100-6
17. Hemmeter U, Muller M, Bischof R, et al. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology 2000; 147: 384-96
18. Allain H., Bentue-Ferrer D., Tarral A., et al. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3,75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomised, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol 2003; 59: 179-88
19. Deakin JB, Rahman S, Nestor PJ, et al. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomised controlled trial. Psychopharmacology, 2004; 172: 400-8
20. Strachan J, Sheperd J. Hyponatremia associated with the use of selective serotonine re-uptake inhibitors. Aust N Z J Psychiatry 1998; 32: 295-8
21. Moulignier A, Allo S, Zittoun R, et al. Recombinant interferon-alpha-induced chorea and frontal subcortical dementia. Neurology 2002; 58: 328-30
22. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-58
23. Maxwell CJ, Hogan DB, Ebly EM. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 1999; 161: 501-6